Back to Search Start Over

Gut microbiome and metabolome signatures in liver cirrhosis-related complications.

Authors :
Sharma SP
Gupta H
Kwon GH
Lee SY
Song SH
Kim JS
Park JH
Kim MJ
Yang DH
Park H
Won SM
Jeong JJ
Oh KK
Eom JA
Lee KJ
Yoon SJ
Ham YL
Baik GH
Kim DJ
Suk KT
Source :
Clinical and molecular hepatology [Clin Mol Hepatol] 2024 Oct; Vol. 30 (4), pp. 845-862. Date of Electronic Publication: 2024 Jul 25.
Publication Year :
2024

Abstract

Background/aims: Shifts in the gut microbiota and metabolites are interrelated with liver cirrhosis progression and complications. However, causal relationships have not been evaluated comprehensively. Here, we identified complication-dependent gut microbiota and metabolic signatures in patients with liver cirrhosis.<br />Methods: Microbiome taxonomic profiling was performed on 194 stool samples (52 controls and 142 cirrhosis patients) via V3-V4 16S rRNA sequencing. Next, 51 samples (17 controls and 34 cirrhosis patients) were selected for fecal metabolite profiling via gas chromatography mass spectrometry and liquid chromatography coupled to time-of-flight mass spectrometry. Correlation analyses were performed targeting the gut-microbiota, metabolites, clinical parameters, and presence of complications (varices, ascites, peritonitis, encephalopathy, hepatorenal syndrome, hepatocellular carcinoma, and deceased).<br />Results: Veillonella bacteria, Ruminococcus gnavus, and Streptococcus pneumoniae are cirrhosis-related microbiotas compared with control group. Bacteroides ovatus, Clostridium symbiosum, Emergencia timonensis, Fusobacterium varium, and Hungatella_uc were associated with complications in the cirrhosis group. The areas under the receiver operating characteristic curve (AUROCs) for the diagnosis of cirrhosis, encephalopathy, hepatorenal syndrome, and deceased were 0.863, 0.733, 0.71, and 0.69, respectively. The AUROCs of mixed microbial species for the diagnosis of cirrhosis and complication were 0.808 and 0.847, respectively. According to the metabolic profile, 5 increased fecal metabolites in patients with cirrhosis were biomarkers (AUROC >0.880) for the diagnosis of cirrhosis and complications. Clinical markers were significantly correlated with the gut microbiota and metabolites.<br />Conclusion: Cirrhosis-dependent gut microbiota and metabolites present unique signatures that can be used as noninvasive biomarkers for the diagnosis of cirrhosis and its complications.

Details

Language :
English
ISSN :
2287-285X
Volume :
30
Issue :
4
Database :
MEDLINE
Journal :
Clinical and molecular hepatology
Publication Type :
Academic Journal
Accession number :
39048520
Full Text :
https://doi.org/10.3350/cmh.2024.0349